Notably, bedaquiline—an established inhibitor of adenosine triphosphate (ATP) synthase in drug-resistant pulmonary tuberculosis (72)—was identified as a candidate inverter of USP33 and CUL5 activity. The gene discussed is CUL5; the disease is pulmonary tuberculosis.